Omniscient Neurotechnology Raises $20 Million as Part of $36 Million…

Team S · 2026-01-21T13:22:13.000Z

Omniscient Neurotechnology, an Australian space in AI-driven connectomics and brain mapping, has secured a $20 million investment from Australia’s National Reconstruction Fund Corporation (NRFC) as part of an ongoing $36 million Series D funding round. The financing will support global commercialisation of its proprietary AI platform Quicktome, which generates personalized brain maps from MRI scans and is already used by major hospitals and research institutions worldwide. The Series D round is being co-led by NRFC and OIF Ventures, with NRFC taking a preferred equity stake in the company. Omniscient plans to deploy the new capital to expand and commercialise Quicktome, grow its data science team, and develop next-generation clinical applications of its connectomics technology. The startup also unveiled plans to establish a connectomics centre of excellence in Sydney and accelerate expansion into the United States where Quicktome has garnered regulatory approval and clinical adoption. Founded in 2019 by experienced technology leaders and neuroscientists, Omniscient operates in the emerging field of connectomics, which aims to comprehensively map and interpret individual brain connections to enable more precise clinical insights. With its FDA-approved platform, the company’s mission is to transform brain health care by providing clinicians with individualized risk and planning tools that improve patient outcomes across neurosurgery, neurology, and related fields.

Member Login Get Access

Omniscient Neurotechnology Raises $20 Million as Part of $36 Million… | Newnex